AU2001291159A1 - Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications - Google Patents

Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications

Info

Publication number
AU2001291159A1
AU2001291159A1 AU2001291159A AU9115901A AU2001291159A1 AU 2001291159 A1 AU2001291159 A1 AU 2001291159A1 AU 2001291159 A AU2001291159 A AU 2001291159A AU 9115901 A AU9115901 A AU 9115901A AU 2001291159 A1 AU2001291159 A1 AU 2001291159A1
Authority
AU
Australia
Prior art keywords
inhalable
medications
nasal
preserved
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291159A
Inventor
Given Not
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shahinian Jr Lee
Original Assignee
LEE SHAHINIAN JR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEE SHAHINIAN JR filed Critical LEE SHAHINIAN JR
Publication of AU2001291159A1 publication Critical patent/AU2001291159A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
AU2001291159A 2000-09-20 2001-09-20 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications Abandoned AU2001291159A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23431900P 2000-09-20 2000-09-20
US60234319 2000-09-20
PCT/US2001/029485 WO2002024116A1 (en) 2000-09-20 2001-09-20 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications

Publications (1)

Publication Number Publication Date
AU2001291159A1 true AU2001291159A1 (en) 2002-04-02

Family

ID=22880873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291159A Abandoned AU2001291159A1 (en) 2000-09-20 2001-09-20 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications

Country Status (5)

Country Link
US (2) US6572849B2 (en)
EP (1) EP1328214A4 (en)
AU (1) AU2001291159A1 (en)
CA (1) CA2423354C (en)
WO (1) WO2002024116A1 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US20050080043A1 (en) * 2000-09-20 2005-04-14 Lee Shahinian Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
WO2002049611A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic lubricating solution adapted for use in lasik surgery
US6878694B2 (en) 2000-12-20 2005-04-12 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
CN1314452C (en) * 2002-04-22 2007-05-09 沈阳药科大学 Ocular in-situ gel preparatino with proper phase conversion temperature
US20050129622A1 (en) * 2002-06-20 2005-06-16 Isabelle Rault Nasal composition comprising a mucopolysaccharide and propylene glycol
US20040101563A1 (en) * 2002-07-18 2004-05-27 Kundu Subhas C. Storage stable antihistaminic syrup formulations
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
EA008496B1 (en) * 2002-12-20 2007-06-29 Чакшу Рисерч, Инк. Ophthalmic formulation for the prevention and treatment of ocular conditions
US20050031652A1 (en) * 2003-02-25 2005-02-10 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050147584A1 (en) * 2004-01-05 2005-07-07 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050084508A1 (en) * 2003-07-22 2005-04-21 Vancaillie Thierry G. Topical anesthesia formulation for bodily cavities
DE10337186A1 (en) * 2003-08-13 2005-03-17 Merck Patent Gmbh Aqueous drug solution
WO2005065185A2 (en) * 2003-12-24 2005-07-21 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
US20050277698A1 (en) * 2004-01-05 2005-12-15 Hughes Patrick M Memantine delivery to the back of the eye
US20050222101A1 (en) * 2004-03-30 2005-10-06 Jeffrey Hutterer Method and composition for treatment of skin conditions
KR20070024558A (en) * 2004-05-27 2007-03-02 산텐 세이야꾸 가부시키가이샤 Thickener for ophthalmic use
JP4207858B2 (en) * 2004-07-05 2009-01-14 セイコーエプソン株式会社 Semiconductor device, display device and electronic apparatus
US7820639B2 (en) * 2004-10-01 2010-10-26 Lindstrom Richard L Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
FR2877576B1 (en) * 2004-11-08 2007-03-09 Ahmed Kadri PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION
EP1907006A2 (en) * 2005-07-15 2008-04-09 Chakshu Research, Inc. Prevention and treatment of ophthalmic complications of diabetes
KR101424518B1 (en) 2005-09-29 2014-08-06 노바르티스 아게 Antibiotic formulations, unit doses, kits, and methods
AU2006201233B2 (en) * 2006-03-24 2010-10-07 Alan Hewitt Topical anesthesia formulation for bodily cavities
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
AU2016219620B2 (en) * 2006-04-21 2017-05-11 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2013206808B2 (en) * 2006-04-21 2016-06-16 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
JP2009535342A (en) * 2006-04-26 2009-10-01 アーシエックス， インコーポレイテッド Composition for prevention and treatment of eyelid swelling
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
AU2007251156A1 (en) * 2006-05-11 2007-11-22 Eran Eilat Eye medicament dispenser
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
US7887859B2 (en) * 2006-11-02 2011-02-15 Riolan Technologies, Inc. Methods of treating epiphora
JP5083502B2 (en) * 2006-12-25 2012-11-28 ライオン株式会社 Ophthalmic composition
BRPI0811254A2 (en) * 2007-04-06 2014-11-04 Senju Pharma Co SUSPENSION FOR EYE TRANSPARENT FABRIC VIEW
KR20100031608A (en) * 2007-06-26 2010-03-23 와카모토 세이야꾸 가부시끼가이샤 Aqueous composition
DE102007052380A1 (en) † 2007-10-31 2009-05-07 Bitop Ag Osmolyte-containing preparations for use in dry mucous membranes
WO2009073213A1 (en) * 2007-12-05 2009-06-11 Avedro, Inc. Eye therapy system
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
WO2010039854A1 (en) * 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
US20100286156A1 (en) * 2009-05-06 2010-11-11 Roberto Pinelli Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
EP3556330A1 (en) 2010-03-19 2019-10-23 Avedro, Inc. Systems for applying and monitoring eye therapy
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
US9433576B2 (en) 2010-09-29 2016-09-06 Pulmatrix, Inc. Cationic dry powders
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
TWI544922B (en) 2011-05-19 2016-08-11 愛爾康研究有限公司 High concentration olopatadine ophthalmic composition
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
EP2713849B1 (en) 2011-06-02 2017-02-15 Avedro, Inc. Systems for monitoring time based photo active agent delivery or photo active marker presence
CN104487075A (en) 2012-02-29 2015-04-01 普马特里克斯公司 Inhalable dry powders
EP4074294A1 (en) 2012-07-16 2022-10-19 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
AU2014228324B2 (en) * 2013-03-15 2019-01-31 Janssen Pharmaceutica Nv Pharmaceutical composition of S-ketamine hydrochloride
SG11201507347QA (en) 2013-03-15 2015-10-29 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
JP6473738B2 (en) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド Tiotropium dry powder
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9034401B1 (en) 2014-01-23 2015-05-19 Matrixx Initiatives, Inc. Pharmaceutical compositions comprising plant extracts and methods for reducing duration of a common cold using same
AU2015318123A1 (en) 2014-09-15 2017-03-30 Janssen Pharmaceutica Nv Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression
DE102014013751A1 (en) * 2014-09-22 2016-03-24 Justus-Liebig-Universität Giessen Pulmonary drug formulation with delayed release
EP3212140B1 (en) 2014-10-27 2021-12-01 Avedro, Inc. Systems for cross-linking treatments of an eye
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
US10258809B2 (en) 2015-04-24 2019-04-16 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP3297589A4 (en) 2015-05-22 2019-03-06 Avedro Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
WO2016196401A1 (en) * 2015-05-29 2016-12-08 The Texas A&M University System Antimicrobial and anti-inflammatory compositions
CN116832158A (en) 2015-07-21 2023-10-03 艾维德洛公司 Systems and methods for treating eyes with photosensitizers
US10632202B2 (en) 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
AU2018349244A1 (en) * 2017-10-11 2020-05-28 Lifescience As N-acetylneuraminic acid compositions and methods of use
US10293047B1 (en) 2017-11-15 2019-05-21 Paragon BioTeck, Inc. Fluorescein and benoxinate compositions
CN117531017A (en) 2017-12-22 2024-02-09 詹森药业有限公司 Esketamine for treating depression
LT3681500T (en) 2018-04-24 2022-06-27 Allergan, Inc. Use of pilocarpine hydrochloride for the treatment of presbyopia
CA3131929A1 (en) 2019-03-05 2020-09-10 Janssen Pharmaceuticals, Inc. Esketamine for the treatment of depression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2141775T3 (en) * 1993-04-16 2000-04-01 Wakamoto Pharma Co Ltd REVERSIBLE THERMALLY GELING MEDICINAL WATER BASED COMPOSITION.
WO1995000143A1 (en) * 1993-06-24 1995-01-05 Leiras Oy Composition for ophthalmic use
WO1995002411A1 (en) * 1993-07-16 1995-01-26 Mallinckrodt Veterinary Limited Stabilised polypeptide growth factor formulation at low ph
KR100215739B1 (en) * 1994-10-13 1999-08-16 오쿠다 기요아키 Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
CA2303132C (en) * 1997-09-11 2002-07-09 Jorge C. De Meireles Intranasal formulations containing scopolamine and method of treating motion sickness
NZ515783A (en) * 1999-06-16 2004-05-28 Nastech Pharmaceutical Co Pharmaceutical formulations and methods comprising intranasal morphine
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same

Also Published As

Publication number Publication date
US20020061340A1 (en) 2002-05-23
CA2423354C (en) 2009-12-15
CA2423354A1 (en) 2002-03-28
EP1328214A1 (en) 2003-07-23
US20040018252A1 (en) 2004-01-29
EP1328214A4 (en) 2009-07-29
WO2002024116A1 (en) 2002-03-28
US6572849B2 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
AU2001291159A1 (en) Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
AU2001257326A1 (en) Topical anesthetic/opioid formulations and uses thereof
AU2001248673A1 (en) Nasal inhaler
AU7859800A (en) Topical nasal treatment
AU6271401A (en) Drug administering system and administering method
AU2001244188A1 (en) Medicaments against viral diseases
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HK1077832A1 (en) 17a-ALKYL-17ß-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE FRODUCTION THEREOF, AND USE OF SAID 17a-ALKYL-17ß-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
AU2002338494A1 (en) Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
AU2002343739A1 (en) Improved therapy for topical diseases
AU2001245572A1 (en) Improvements for the storage and delivery of multi-dose, preservative-free pharmaceuticals
AU5286901A (en) Topical anesthetic formulation
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2002366799A1 (en) Allantoin-containing preparations for administration as gels and aerosols
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2001267887A1 (en) Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
AU2002361850A1 (en) Medicinal aerosol formulations comprising ion pair complexes
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2002210439A1 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2001247793A1 (en) Financial product administration system and methods
AU2001274236A1 (en) Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist